Recruitment

Recruitment Status
Enrolling by invitation
Estimated Enrollment
20

Summary

Conditions
Chronic Kidney Disease
Type
Interventional
Phase
Phase 2
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 40 years and 80 years
Gender
Both males and females

Description

The proposed studies will examine cellular senescence and the effect of senolytic therapy on senescent cell burden, frailty, and adipose-derived mesenchymal stem cell function in individuals with diabetic chronic kidney disease.

The proposed studies will examine cellular senescence and the effect of senolytic therapy on senescent cell burden, frailty, and adipose-derived mesenchymal stem cell function in individuals with diabetic chronic kidney disease.

Tracking Information

NCT #
NCT02848131
Collaborators
Not Provided
Investigators
Principal Investigator: LaTonya J Hickson, MD Mayo Clinic